Short-term eplerenone for treatment of chronic central serous chorioretinopathy; a prospective study

BACKGROUND: Increased mineralocorticoid activity is one of the plausible causes of chronic central serous chorioretinopathy (CSCR) and mineralocorticoid inhibitors such as eplerenone have been investigated as its potential therapy. This study investigates the short-term safety and efficacy of oral e...

Descripción completa

Detalles Bibliográficos
Autores principales: Moein, Hamid-Reza, Bierman, Lauren W., Novais, Eduardo A., Moreira-Neto, Carlos, Baumal, Caroline R., Rogers, Adam, Duker, Jay S., Witkin, André J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6734298/
https://www.ncbi.nlm.nih.gov/pubmed/31516734
http://dx.doi.org/10.1186/s40942-019-0190-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6734298/
https://www.ncbi.nlm.nih.gov/pubmed/31516734
http://dx.doi.org/10.1186/s40942-019-0190-y

Ejemplares similares